Clear Harbor Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-60,330	Closed	-$485K	–	291
2018 Q2	$485K	Hold	60,330	–	–	0.09%	144
2018 Q1	$450K	Sell	60,330 -1,680	-3%	-$11.2K	0.09%	146
2017 Q4	$369K	Sell	62,010 -660	-1%	-$4.01K	0.07%	163
2017 Q3	$461K	Sell	62,670 -9,260	-13%	-$58.8K	0.09%	153
2017 Q2	$493K	Buy	71,930 +19,330	+37%	+$143K	0.09%	145
2017 Q1	$497K	Hold	52,600	–	–	0.1%	142
2016 Q4	$454K	Sell	52,600 -810	-2%	-$5.99K	0.1%	143
2016 Q3	$338K	Sell	53,410 -2,850	-5%	-$17.2K	0.07%	170
2016 Q2	$237K	Sell	56,260 -540	-1%	-$2.61K	0.05%	210
2016 Q1	$248K	Sell	56,800 -50	-0.1%	-$223	0.05%	196
2015 Q4	$348K	Sell	56,850 -810	-1%	-$5.31K	0.08%	171
2015 Q3	$330K	Sell	57,660 -120	-0.2%	-$921	0.08%	190
2015 Q2	$431K	Buy	57,780 +300	+0.5%	+$1.81K	0.08%	177
2015 Q1	$344K	Sell	57,480 -2,070	-3%	-$13K	0.07%	201
2014 Q4	$450K	Sell	59,550 -10,150	-15%	-$60.7K	0.09%	176
2014 Q3	$362K	Buy	69,700 +47,600	+215%	+$237K	0.08%	152
2014 Q2	$95K	Buy	22,100 +3,100	+16%	+$11.8K	0.02%	212
2014 Q1	$78K	Sell	19,000 -1,000	-5%	-$5.11K	0.02%	202
2013 Q4	$107K	Buy	+20,000	New	+$88K	0.03%	175